Nuplazid (pimavanserin) is more effective in reducing severe psychotic symptoms — particularly hallucinations and delusions — in Alzheimer’s…
Articles by Marta Figueiredo, PhD
Researchers have identified two biomarkers that could help determine which Alzheimer’s disease patients can benefit from Anavex 2-73 treatment.
Verubecestat (MK-8931) indeed failed to slow cognitive and functional decline in mild-to-moderate Alzheimer’s patients despite some reduction in beta-amyloid levels…
New data on how Allergan’s Namenda (memantine) — given in combination with cholinesterase inhibitors — works to help ease some…
A new algorithm can quantify faster and more effectively the amount of brain amyloid plaques during positron emission tomography (PET)…
Results from a pilot Phase 4 clinical trial evaluating the potential benefit of a known blood pressure and heart failure…
CTD Holdings and the Kerwin Research Center are discussing working together on the use of cholesterol-lowering therapies called cyclodextrins as possible treatments…